Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02101)

• Formulation Name: Auranofin 3 mg capsule
• Company: Prometheus Laboratories; Sebela Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Auranofin	(DMWE2N4)	Inflammatory arthritis	FA2Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Benzyl alcohol	(E00010)	244	Antimicrobial preservative; Solvent
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Cetylpyridinium chloride	(E00330)	31239	Antimicrobial preservative; Penetration agent; Solubilizing agent; Surfactant
D&C red no. 33	(E00261)	19116	Colorant
FD&C blue no. 1	(E00263)	19700	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent